Question 70 of 106 in In the News 2021
Started Mar 12, 2021 06:00PM UTC   •   Closing Oct 01, 2021 07:01AM UTC

The Economist asks:

Will the US FDA approve the drug molnupiravir for use to treat COVID-19 before 1 October 2021?

Molnupiravir, a drug being developed by Merck and Ridgeback Biotherapeutics, has shown positive results in clinical trials in combatting COVID-19 (Economist, Fox News, Merck). “Compassionate use" and "emergency use" authorizations would count (FDA, FDA).

Confused? Check our FAQ or ask us for help. To learn more about Good Judgment and Superforecasting, click here.

To learn more about how you can become a Superforecaster, see hereFor other posts from our Insights blog, click here.

NOTE 3 August 2021: FDA approval for molnupiravir for use in combination with other therapeutics to treat COVID-19 would count.

Current Crowd Forecast


+0.00% in last 24 hours

Sign up or sign in to forecast!

Sign Up Sign In
Tip: Mention someone by typing @username